TATALAKASANA TERKINI HIPERTENSI PULMONER PADA ANAK

Penulis

  • Dyahris Koentartiwi Universitas Brawijaya
  • Ardhanis Ramadhanti Universitas Brawijaya
  • Ervan Aditya Putra Chafid Universitas Brawijaya

DOI:

https://doi.org/10.20527/jps.v10i2.13407

Kata Kunci:

Penyakit Jantung Bawaan, Hipertensi Pulmoner, Anak, Left-to-right Shunt, Vasodilator

Abstrak

Hipertensi pulmoner (HP) merupakan suatu kondisi dimana terjadi peningkatan tekanan vaskular paru yang berkaitan dengan berbagai etiologi. Pada anak, sekitar 50% HP seringkali ditemukan pada pasien dengan penyakit jantung bawaan dengan left-to-right shunt, penyakit pulmonal, gangguan perkembangan paru serta idiopatik. Insiden HP pada anak secara umum dilaporkan sebesar 4-10 kasus per 1 juta anak per tahun. Terapi koreksi secara operatif atau kateterisasi masih menjadi pilihan utama untuk koreksi HP. Namun tingkat morbiditas dan mortalitas paska koreksi dilaporkan cukup tinggi. Oleh karena itu, beberapa studi terus mengkaji dan mengembangkan pilihan terapi untuk HP. Beberapa diantaranya adalah terapi vasodilator dengan PDE-5, CCB, analog prostasiklin dan inhalasi NO. Karena etiologi yang sangat komplek dan belum banyak bukti klinis atau konsensus tentang tatalaksana HP pada anak, maka pemilihan terapi HP yang sesuai masih cukup sulit. Pada prinsipnya tujuan utama dari terapi HP adalah meningkatkan angka harapan hidup dan memfasilitasi pasien agar dapat melakukan aktivitas secara mandiri tanpa limitasi. Tujuan dari penulisan tinjauan kepustakaan ini adalah untuk membahas tentang tatalaksana terkini HP pada anak sehingga diharapkan dapat menambah pengetahuan dan referensi sebagai dasar praktis klnis tentang tatalaksana HP pada anak.

Biografi Penulis

Dyahris Koentartiwi, Universitas Brawijaya

Divisi Kardiologi, Departemen Ilmu Kesehatan Anak, Fakultas Kedokteran 

Ardhanis Ramadhanti, Universitas Brawijaya

Divisi Kardiologi, Departemen Ilmu Kesehatan Anak, Fakultas Kedokteran 

Ervan Aditya Putra Chafid, Universitas Brawijaya

Program Pendidikan Dokter Spesialis, Departemen Ilmu Kesehatan Anak, Fakultas Kedokteran 

Referensi

Albinni, S., Marx, M., & Lang, I. M. (2020). Focused update on pulmonary hypertension in children—selected topics of interest for the adult cardiologist. In Medicina (Lithuania), 56(9), 1-34. https://doi.org/10.3390/medicina56090420

Beghetti, M., Puigdefabregas, J. W. B., & Merali, S. (2014). Sildenafil for the treatment of pulmonary hypertension in children. In Expert Review of Cardiovascular Therapy, 12(10), 1157-1184. https://doi.org/10.1586/14779072.2014.958077

Dobashi, S., Watanabe, I., Nakanishi, R., Hisatake, S., Kiuchi, S., Kabuki, T., Oka, T., Fujii, T., & Ikeda, T. (2020). Comparing the effects of milrinone and olprinone in patients with congestive heart failure. Heart and Vessels, 35(6), 776–785. https://doi.org/10.1007/s00380-019-01543-6

Durongpisitkul, K., Chungsomprasong, P., Vijarnsorn, C., Chanthong, P., Kanjanauthai, S., & Soongswang, J. (2021). Improved low-risk criteria scores for combination therapy of sildenafil and generic bosentan in patients with congenital heart disease with severe pulmonary hypertension: A prospective open label study. JRSM Cardiovascular Disease, 10(1), 1-6. https://doi.org/10.1177/2048004020982213

Frank, B. S., & Ivy, D. D. (2020). Pediatric Pulmonary Arterial Hypertension: Evaluation and Treatment. In Current Treatment Options in Pediatrics, 6(1), 12-28. https://doi.org/10.1007/s40746-020-00186-4

Galiè, N., Humbert, M., Vachiery, J. L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., Ghofrani, A., Gomez Sanchez, M. A., Hansmann, G., Klepetko, W., Lancellotti, P., Matucci, M., McDonagh, T., Pierard, L. A., Trindade, P. T., … Sirenko, Y. (2016). 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal, 37(1), 67–119. https://doi.org/10.1093/eurheartj/ehv317

Gorenflo, M., & Ziesenitz, V. C. (2021). Treatment of pulmonary arterial hypertension in children. Cardiovascular Diagnosis and Therapy, 11(4), 1144–1159. https://doi.org/10.21037/cdt-20-912

Hansmann, G. (2017). Pulmonary Hypertension in Infants, Children, and Young Adults. J AM Coll Cardiol, 69(20), 2551-2569.

Hansmann, G., & Apitz, C. (2016). Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart, 102, 67–105. https://doi.org/10.1136/heartjnl-2015-309103

Ivy, D. D., Abman, S. H., Barst, R. J., Berger, R. M. F., Bonnet, D., Fleming, T. R., Haworth, S. G., Raj, J. U., Rosenzweig, E. B., Schulze Neick, I., Steinhorn, R. H., & Beghetti, M. (2013). Pediatric pulmonary hypertension. Journal of the American College of Cardiology, 62(25) 117-126. https://doi.org/10.1016/j.jacc.2013.10.028

Kam, C. W., & Ruiz, F. E. (2021). Opportunities and challenges of pharmacotherapy for pulmonary arterial hypertension in children. In Pediatric Pulmonology, 56(3), 593–613. https://doi.org/10.1002/ppul.25101

Kuntartiwi, D., Yanuarso, P. B., & Sastroasmoro, S. (n.d.) (2015). Sildenafil for pulmonary hypertension due to left-to-right shunt after corrective procedure. In Paediatrica Indonesiana Original Article, 55(5), 257-261.

Lan, N., Massam, B., Kulkarni, S., & Lang, C. (2018). Pulmonary Arterial Hypertension: Pathophysiology and Treatment. Diseases, 6(2), 1-22. https://doi.org/10.3390/diseases6020038

McLaughlin, V. V., Shah, S. J., Souza, R., & Humbert, M. (2015). Management of pulmonary arterial hypertension. In Journal of the American College of Cardiology, 65(18), 1976–1997. https://doi.org/10.1016/j.jacc.2015.03.540

Olguntürk, F. R. (2020). An update on the diagnosis and treatment of pediatric pulmonary hypertension. In Expert Opinion on Pharmacotherapy, 21(10), 1253–1268. https://doi.org/10.1080/14656566.2020.1757071

Park, M. K. (2021). PEDIATRIC CARDIOLOGY FOR PRACTITIONERS Seventh Edition. https://doi.org/10.1016/B978-0-323-68107-0.01001-7

Qasim, A., & Jain, S. K. (2020). Milrinone Use in Persistent Pulmonary Hypertension of the Newborn Practice Gaps. Neoreview Journal of the American Academy of Pediatrics, 21(3), 165-176. http://neoreviews.aappublications.org/

Rosenzweig, E. B., Abman, S. H., Adatia, I., Beghetti, M., Bonnet, D., Haworth, S., Ivy, D. D., & Berger, R. M. F. (2019). Paediatric pulmonary arterial hypertension: Updates on definition, classification, diagnostics and management. European Respiratory Journal, 53(1) 1-18. https://doi.org/10.1183/13993003.01916-2018

Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., Olschewski, H., Robbins, I. M., & Souza, R. (2013). Updated clinical classification of pulmonary hypertension. Journal of the American College of Cardiology, 62(25), 34-41. https://doi.org/10.1016/j.jacc.2013.10.029

Thomas, C. A., Anderson, R. J., Condon, D. F., Vinicio, V. A., (2019). Diagnosis and Management of Pulmonary Hypertension in the Modern Era: Insights from the 6th World Symposium. Pulm Ther, 6(1), 9-22. https://doi.org/10.6084/m9.figshare.10304645.

##submission.downloads##

Diterbitkan

2023-10-23

Terbitan

Bagian

Jurnal Pharmascience